Geographic AtrophySymptoms, Doctors, Treatments, Advances & More
Learn About Geographic Atrophy
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Cleveland Clinic Main Campus
Peter Kaiser is an Ophthalmologist in Cleveland, Ohio. Dr. Kaiser has been practicing medicine for over 38 years and is rated as an Elite provider by MediFind in the treatment of Geographic Atrophy. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Vitrectomy, and Osteotomy.
Retina Vitreous Associates Of FL
David Eichenbaum is an Ophthalmologist in St Petersburg, Florida. Dr. Eichenbaum is rated as an Elite provider by MediFind in the treatment of Geographic Atrophy. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Diabetic Macular Edema (DME), and Vitrectomy.
Southeastern Retina Associates
. Dr. Kleinman is rated as a Distinguished provider by MediFind in the treatment of Geographic Atrophy. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Geographic Atrophy, and Central Serous Chorioretinopathy.
Summary: Age-related macular degeneration (AMD) is the abnormal growth of new blood vessels in the light-sensitive tissue at the back of the eye called the retina. Geographic Atrophy (GA) is an advanced form of dry AMD. The purpose of this study is to assess the adverse events and how intravitreal ABBV-6628 moves through the body of adult participants with secondary to age-related macular degeneration ABBV...
Summary: This is a clinical study to evaluate the safety, tolerability and efficacy of CTx001, administered via a single subretinal injection, for GA (secondary to AMD). Safety and efficacy will be measured at regular intervals for 2 years after which long-term safety will be assessed annually for up to 5 years.